The former general counsel of Intermune Inc. isn’t on trial. But he wound up figuring large in a rare health care fraud prosecution that Northern District of California Judge Marilyn Hall Patel has sent to the jury.
During closing arguments Wednesday, both sides used evidence from former GC Steven Rosenfeld to debate whether former CEO W. Scott Harkonen crafted a deceptive press release designed to boost sales of a controversial, but ineffective, drug.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
